Clinical Trial Update: Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating Mirena for six months as a treatment for nonatypical endometrial hyperplasia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Hyperplasia

Drugs mentioned

• Mirena (levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: Bayer | Conditions: Endometrial Hyperplasia | Phase 3 | Status: RECRUITING